Literature DB >> 16678502

Inhalation solutions: which one are allowed to be mixed? Physico-chemical compatibility of drug solutions in nebulizers.

Wolfgang Kamin1, Astrid Schwabe, Irene Krämer.   

Abstract

Therapy of chronic respiratory diseases often involves inhalation therapy with nebulizers. Patients often attempt to shorten the time consuming administration procedure by mixing drug solutions/suspensions for simultaneous inhalation. This article considers the issue of physico-chemical compatibility of admixtures of drug solutions/suspensions in nebulizers. A search of databases, prescribing information and primary literature was conducted to locate literature concerning the physico-chemical compatibility of inhalation solutions/suspensions. This was supplemented by telephone interviews. Admixtures of albuterol with ipratropium and/or cromolyn, of albuterol and budesonide, or tobramycin, or colistin are physico-chemically compatible. Physico-chemical compatibility has been demonstrated for admixtures of cromolyn with albuterol and/or ipratropium and for admixtures of cromolyn and budesonide. Admixtures of budesonide with ipratropium and/or fenoterol, and admixtures of budesonide and albuterol, or cromolyn are physico-chemically compatible. Both cromolyn and colistin are incompatible with benzalkonium chloride. Admixtures should be prepared from inhalation solutions/suspensions formulated without preservatives. Besides studies of the physico-chemical compatibility, the aerodynamic behaviour of physico-chemical mixtures needs to be studied before a final recommendation of simultaneous nebulization of compatible admixtures can be made.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16678502     DOI: 10.1016/j.jcf.2006.03.007

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  4 in total

1.  What makes flunisolide different among inhaled corticosteroids used for nebulization: a close look at the role of aqueous solubility.

Authors:  Ahmad Kantar
Journal:  Multidiscip Respir Med       Date:  2021-01-15

2.  Physicochemical compatibility of fluticasone-17- propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions.

Authors:  Wolfgang Kamin; Astrid Schwabe; Irene Krämer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

3.  Why the lower reported prevalence of asthma in patients diagnosed with COVID-19 validates repurposing EDTA solutions to prevent and manage treat COVID-19 disease.

Authors:  Daniel P Cashman
Journal:  Med Hypotheses       Date:  2020-06-26       Impact factor: 1.538

4.  Aerosol Characteristics and Physico-Chemical Compatibility of Combivent® (Containing Salbutamol and Ipratropium Bromide) Mixed with Three Other Inhalants: Budesonide, Beclomethasone or N-Acetylcysteine.

Authors:  Rui Zhang; Junhua Hu; Liangjun Deng; Sha Li; Xi Chen; Fei Liu; Shanping Wang; Khaja Shameem Mohammed Abdul; Huimin Beng; Wen Tan
Journal:  Pharmaceutics       Date:  2020-01-17       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.